In this on demand webinar, hosted by DDW and sponsored by Elegen, learn about the breakthroughs in mRNA drug discovery and development.
You will hear from Carsten Rudolph, Managing Director and CEO of Ethris, Klaas Zuideveld, CEO of Versameb, as well as Matthew Hill, Founder and CEO of Elegen.
What you will learn:
- What are the challenges in relation to the development of mRNA therapeutics and how can they be overcome?
- What do we know about the mRNA pipeline and which disease areas offer opportunity?
- What does the future hold for mRNA drugs and therapeutics and where should the sector be placing its focus for long-term success?
An audience Q&A session with the presenters follows the webinar presentation.
